Mid Atlantic Epilepsy and Sleep Center

Recent papers from Mid Atlantic Epilepsy and Sleep Center

1. Narrative Review: Efficacy, Safety, and Tolerability of Newer Third-Generation Antiseizure Medications for Focal Epilepsy: A New Benchmark in Treatment Outcomes?Neurology and Therapy · 2026
2. The “Hope, Hesitancy, and Hard Truths” Survey: A Patient and Provider Perspective on Epilepsy Treatment (P11-11.002)Neurology · 2026
3. Intra-nasal Seletracetam for Reading Epilepsy: A First in Human Proof-of-concept Case Study (P5-11.001)Neurology · 2026
4. Efficacy and Safety of Adjunctive Cenobamate for the Treatment of Primary Generalized Tonic-clonic Seizures in Adults and Adolescents (P3-10.003)Neurology · 2026
5. A consensus roadmap for post‐traumatic epilepsy: Clinical biomarkers, research priorities, policy barriers, and pathways to interventional trialsEpilepsia · 2026
6. The Discovery of Cenobamate: A Drug with High Efficacy in Drug-Resistant EpilepsyCNS Drugs · 2026
7. The Complexity and Challenges of Developing Effective Epilepsy Therapies: Lessons to be Learned from Comparing Cenobamate, Carisbamate, and PadsevonilCNS Drugs · 2026
8. Ranking of antiseizure medications in a panel of focal seizure models predicts their comparative efficacy in clinical add‐on trials in drug‐resistant focal epilepsyEpilepsia · 2026
9. Seletracetam Revisited: A Missed Opportunity for Effective Epilepsy TherapyCNS Drugs · 2026
10. Biomarker discovery in Lennox-Gastaut syndrome: Advances and challenges in electrophysiological, genetic, neuroimaging, and neuroinflammatory approachesEpilepsy & Behavior · 2026
11. Inflammatory proteins as acute biomarkers of post-traumatic epilepsyFrontiers in Neurology · 2025
12. Inflammatory proteins as acute biomarkers of post-traumatic epilepsyFrontiers in Neurology · 2025
13. Pharmacokinetics and tolerability of single‐dose Staccato® alprazolam in adolescents with epilepsy, and population pharmacokinetic analysis to support dose selection in adolescentsEpilepsia · 2025
14. Academia, industry and the slow adoption of new treatmentsBrain · 2025
15. Exploring proposed recommendations for immediate‐use seizure medication: Treating both cluster and prolonged seizures with diazepam nasal sprayEpilepsia Open · 2025
16. Pharmacodynamic interactions between seletracetam and antiseizure comedications in the human photosensitivity modelEpilepsia · 2025
17. Do Seizures Damage the Brain ?—Cumulative Effects of Seizures and Epilepsy: A 2025 PerspectiveEpiliepsy currents/Epilepsy currents · 2025
18. Clinical trials of prevention of acquired epilepsy: New proof‐of‐concept approach to restart trialsEpilepsia · 2025
19. Seizure freedom and reducing the risk of sudden unexpected death in patients with focal epilepsy treated with cenobamate or other antiseizure medicationsEpilepsia · 2025
20. Cenobamate efficacy in specific populationsEpilepsia · 2025